Concepedia

Henry Xiong

HX

16

Publications

2K

Citations

14

H-Index

2004

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Center for Cancer and Blood Disorders

Taiho Pharmaceutical (Japan)

Istituti di Ricovero e Cura a Carattere Scientifico

Florida Cancer Specialists & Research Institute

Henry Xiong is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and radiation oncology.

Top concepts

Publications per year

2004–2023

16

Publications

16

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Gauri R. Varadhachary, Robert A. Wolff, Christopher H. Crane et al. · Journal of Clinical Oncology · 2008 · 466 citations · Full text

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

, , +8

Aggresome Disruption: A Novel Strategy to Enhance Bortezomib-Induced Apoptosis in Pancreatic Cancer Cells

Steffan T. Nawrocki, Jennifer S. Carew, Maria Simona Pino et al. · Cancer Research · 2006 · 241 citations · Full text

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

Milind Javle, Rachna T. Shroff, Henry Xiong et al. · BMC Cancer · 2010 · 164 citations · Full text

Yttrium 90 Resin Microspheres for the Treatment of Unresectable Colorectal Hepatic Metastases after Failure of Multiple Chemotherapy Regimens: Preliminary Results

Ravi Murthy, Henry Xiong, Rodolfo Núñez et al. · Journal of Vascular and Interventional Radiology · 2005 · 151 citations

, , +9

Rows per page

1–5 of 16